BioClinica, Inc. is opening new and expanded offices in London and Munich that will offer clinical trial services including medical imaging, site training and support, and eClinical product lines.
 
Together, the London and Munich offices offer a combined space of 1,400 square meters to support clinical trial services across key therapeutic areas. With a focus on medical imaging, the European offices will have an advanced image analysis center for its network of European radiologists and imaging specialists.
 
“Our new offices will serve as important hubs that enable efficient delivery of tailored resources to our European and Global clients” said John Hubbard, BioClinica’s chief executive officer. “Infrastructure investments and the recruitment of local scientific, medical, and regulatory expertise highlight BioClinica’s firm commitment to supporting clinical drug development in Europe.”